FIRST AMENDED AND RESTATED CELL THERAPY DEVELOPMENT, MANUFACTURING AND/OR TISSUE PROCESSING TERMS AND CONDITIONS BETWEEN WuXi AppTec, Inc. and NewLink Genetics CorporationCell Therapy Development, Manufacturing and/or Tissue Processing Terms and Conditions • May 20th, 2016 • Newlink Genetics Corp • Pharmaceutical preparations • New York
This Restated and Amended Development and Manufacturing Terms and Conditions (the “Agreement”) is made and entered into as of January 4, 2016 by and between WuXi AppTec, Inc., a corporation organized under the laws of Delaware with offices located at 4751 League Island Blvd., Philadelphia, Pennsylvania (“WuXi AppTec”), and NewLink Genetics Corporation, a company organized under the laws of Delaware with offices located at 2503 South Loop Drive, Suite 5100, Ames, IA 50010 and Affiliates (Customer). The terms stated in this Agreement supersede the Development and Manufacturing Terms and Conditions dated June 19, 2014 (Effective Date) between the Parties. Customer and WuXi AppTec are referred to herein individually as a “Party” and collectively as the “Parties”.
